1 Watad A, Kacar M, Bragazzi NL, et al. Somatic mutations and the risk of undifferentiated autoinflammatory disease in MDS: an under-recognized but prognostically important complication. Front Immunol.
2021;12:610019. doi:10.3389/fimmu.2021.610019.
2 Oganesyan A, Hakobyan Y, Terrier B, Georgin-Lavialle S, Mekinian A. Looking beyond VEXAS: coexistence
of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome. Semin Hematol.
2021;58(4):247–253. doi:10.1053/j.seminhematol.2021.10.003.
3 Beck DB, Ferrada MA, Sikora KA, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–2638. doi:10.1056/NEJMoa2026834.
4 Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361(19):1872–1885. doi:10.1056/
NEJMra0902908.
5 Lin YC, Liang TH, Chang HN, Lin JS, Lin HY. Behçet disease associated with myelodysplastic syndrome.
J Clin Rheumatol. 2008;14(3):169–174. doi:10.1097/RHU.0b013e3181776bde.
6 Shen Y, Ma HF, Luo D, Cai JF, Zou J, Guan JL. High incidence of gastrointestinal ulceration and
cytogenetic aberration of trisomy 8 as typical features of Behçet’s disease associated with myelodysplastic
syndrome: a series of 16 consecutive Chinese patients from the Shanghai Behçet’s disease database and
comparison with the literature. Biomed Res Int. 2018;2018:8535091. doi:10.1155/2018/8535091.
7 Wesner N, Drevon L, Guedon A, et al. Inflammatory disorders associated with trisomy 8-myelodysplastic
syndromes: French retrospective case-control study. Eur J Haematol. 2019;102(1):63–69. doi:10.1111/
ejh.13174.
8 Esatoglu SN, Hatemi G, Salihoglu A, Hatemi I, Soysal T, Celik AF. A reappraisal of the association between
Behçet’s disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review.
Clin Exp Rheumatol. 2015;33(6 Suppl 94):S145-S151.
9 Fujimura T, Yukawa N, Nakashima R, et al. Periodic fever and erythema nodosum associated with MDS
with trisomy 8: report of two cases and review of the literature. Mod Rheumatol. 2010;20(4):413–419.
doi:10.1007/s10165-010-0291-9.
10 Jachiet V, Fenaux P, Sevoyan A, et al. Inflammatory and immune disorders associated with myelodysplastic
syndromes. Hemato. 2021;2(2):329–346. doi:10.3390/hemato2020019.
11 Padeh S, Bilginer Y, Ozen S. Familial Mediterranean Fever. In: Hashkes PJ, Laxer RM, Simon A, eds.
Textbook of Autoinflammation. Switzerland: Springer Nature; 2019:chap 16. doi:10.1007/978-3-319-98605-0.
12 Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis
Rheum. 1997;40(10):1879–1885. doi:10.1002/art.1780401023.
13 Migita K, Uehara R, Nakamura Y, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore).
2012;91(6):337–343. doi:10.1097/MD.0b013e318277cf75.
14 Migita K, Agematsu K, Yazaki M, et al. Familial Mediterranean fever: genotype-phenotype correlations in
Japanese patients. Medicine (Baltimore). 2014;93(3):158–164. doi:10.1097/MD.0000000000000029.
15 Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda S. Genotype-phenotype
correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical
features between Japanese and Mediterranean populations. Arthritis Res Ther. 2014;16(5):439. doi:10.1186/
s13075-014-0439-7.
16 Tanaka N, Sakuraba H, Hiraga H, et al. Long-term maintenance of the mucosal healing induced by
azacitidine therapy in a patient with intestinal Behçet’s-like disease accompanied with myelodysplastic
syndrome involving trisomy 8. Immunol Med. 2019;42(3):135–141. doi:10.1080/25785826.2019.1687251.
Nagoya J. Med. Sci. 85. 195–203, 2023
202
doi:10.18999/nagjms.85.1.195
Trisomy 8 MDS with multiple MEFV variants
17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Sarrauste de Menthière C, Terriere S, Pugnère D, Ruiz M, Demaille J, Touitou I. INFEVERS: the registry for
FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res. 2003;31(1):282–285. doi:10.1093/
nar/gkg031.
Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO)
classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood.
2009;114(5):937–951. doi:10.1182/blood-2009-03-209262.
Abbara S, Grateau G, Ducharme-Bénard S, Saadoun D, Georgin-Lavialle S. Association of vasculitis and
familial Mediterranean fever. Front Immunol. 2019;10:763. doi:10.3389/fimmu.2019.00763.
Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behçet’s disease. Hum Mutat. 2000;16(3):271–
272. doi:10.1002/1098-1004(200009)16:3<271::AID-HUMU16>3.0.CO;2-A.
Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis.
Rheumatology (Oxford). 2009;48(1):23–25. doi:10.1093/rheumatology/ken409.
Jo T, Horio K, Migita K. Sweet’s syndrome in patients with MDS and MEFV mutations. N Engl J Med.
2015;372(7):686–688. doi:10.1056/NEJMc1412998.
Alberts B, Johnson A, Lewis J, et al. Chapter 15 Cell Signaling. In: Molecular Biology of the Cell. Sixth
ed. New York: Garland Science; 2017:813–888.
Lorente-Sorolla C, Netea MG, Ballestar E. Epigenetics in Autoinflammation. In: Hashkes PJ, Laxer RM,
Simon A, eds. Textbook of Autoinflammation. Switzerland: Springer Nature; 2019:chap 3. doi:10.1007/9783-319-98605-0.
Glenthøj A, Ørskov AD, Hansen JW, Hadrup SR, O’Connell C, Grønbæk K. Immune mechanisms in
myelodysplastic syndrome. Int J Mol Sci. 2016;17(6):944. doi:10.3390/ijms17060944.
Vander Pluym JH, O’Sullivan J, Andrew G, Bolduc FV. Genomic characterization of chromosome 8
pericentric trisomy. Clin Case Rep. 2015;3(7):570–577. doi:10.1002/ccr3.234.
Schmid JA, Birbach A. IkB kinase b (IKKb/IKK2/IKBKB) — A key molecule in signaling to the transcription
factor NF-kB. Cytokine Growth Factor Rev. 2008;19(2):157–165. doi:10.1016/j.cytogfr.2008.01.006.
Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kB through its N-terminal fragment. Blood. 2008;112(5):1794–1803. doi:10.1182/
blood-2008-01-134932.
Fujikura K. Global epidemiology of familial Mediterranean fever mutations using population exome
sequences. Mol Genet Genom Med. 2015;3(4):272–282. doi:10.1002/mgg3.140.
Bernot A, Da Silva C, Petit JL, et al. Non-founder mutations in the MEFV gene establish this gene as
the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998;7(8):1317–1325. doi:10.1093/
hmg/7.8.1317.
Fujimoto K, Hidaka Y, Koga T, et al. MEFV E148Q variant is more associated with familial Mediterranean
fever when combined with other non-exon 10 MEFV variants in Japanese patients with recurrent fever.
Mod Rheumatol. 2021;31(6):1208–1214. doi:10.1080/14397595.2021.1880534.
Miyoshi T, Yamashita K, Ohno T, et al. Familial Mediterranean fever gene as a possible modifier of Sweet
syndrome with chronic myelogenous leukemia. Acta Haematol. 2008;120(1):57–62. doi:10.1159/000158578.
Sugie M, Ouchi T, Kishida D, Yasaki S. Atypical type of familial Mediterranean fever: an underdiagnosed
cause of chronic aseptic meningitis. Neurol Clin Neurosci. 2018;6(6):191–193. doi:10.1111/ncn3.12232.
Kimura K, Mizooka M, Migita K, et al. Five cases of familial Mediterranean fever in Japan: the relationship
with MEFV mutations. Intern Med. 2018;57(16):2425–2429. doi:10.2169/internalmedicine.0057-17.
Sato T, Takezaki S, Goto T, et al. Atypical familial Mediterranean fever in a Japanese boy with heterozygous
MEFV p. Ser503Cys exon 5 variant. Case Rep Pediatr. 2021;2021:6650226. doi:10.1155/2021/6650226.
Shinar Y, Tohami T, Livneh A, et al. Acquired familial Mediterranean fever associated with a somatic
MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis. Orphanet J Rare Dis.
2015;10:86. doi:10.1186/s13023-015-0298-6.
Komrokji RS, Kulasekararaj A, Al Ali NH, et al. Autoimmune diseases and myelodysplastic syndromes.
Am J Hematol. 2016;91(5):E280-E283. doi:10.1002/ajh.24333.
References End
Nagoya J. Med. Sci. 85. 195–203, 2023
203
doi:10.18999/nagjms.85.1.195
...